Some of the world's greatest discoveries happened by accident. While the discovery of diamond dust's potential as a future MRI contrast agent may never be considered a turning point in science ...

Bayer is on the brink of filing a new MRI contrast agent for approval that can reduce levels of gadolinium, a rare earth metal that can have health and environmental consequences. The company has ...

Bayer’s Gadavist has become the first imaging agent approved in the US to detect blockages in the hearts of patients with known or suspected coronary artery disease (CAD). The magnetic resonance ...

NEUFELD, Austria, Feb. 25, 2025 /PRNewswire/ -- Sanochemia Pharmazeutika today announced positive headline results of the pivotal phase III study PROSTAPROGRESS on Ferumoxtran (EudraCT 2018-004310 ...

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer, a global leader in radiology, announced positive results from the Phase III study QUANTI CNS, which evaluated the investigational gadolinium-based contrast ...